Abiomed, Inc. (ABMD) Tops Q1 EPS by 3c

August 4, 2011 7:29 AM EDT
Abiomed, Inc. (NASDAQ: ABMD) reported Q1 EPS of ($0.03), $0.03 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $27.79 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings